Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05412 (
c-Jun
)
11,453
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Recent studies have indicated that ubiquitously expressed molecular chaperones of the heat shock protein (Hsp) class may have an additional, nuclear, role in the regulation of gene expression. Experiments on cellular transcription factors derived from the rat adrenal gland have now shown that Hsps modulate in vitro DNA binding activity of the AP-1 factor. Both Hsc70 (
p73
) and Hsp70 (p72) were demonstrated to exert this effect through a mechanism that appears to be independent of both redox, and phosphorylation state. Further studies on the effect of Hsps on recombinant Fos/Jun protein binding activity indicated that the mechanism of action involves a selective attenuation of high affinity c-Fos:
c-Jun
binding as compared with
c-Jun
homodimer binding activity. Because cellular and physiological stress are associated with the induction of both AP-1 and Hsps it is apparent that Hsps may play a modulatory role in the regulation of AP-1 responsive genes.
...
PMID:Modulation of cellular AP-1 DNA binding activity by heat shock proteins. 936 38
Chemotherapeutic drugs and stress signals activate
p73
, the structural and functional homologue of p53, both by transcriptional activation and post-translational modifications. However, cisplatin, a DNA damage-inducing chemotherapeutic agent, is thought to regulate
p73
only by affecting its stability through mechanisms involving the MLH-1/c-Abl signaling cascade. Here we show that
c-Jun
, a component of the AP-1 family of transcription factors, contributes to
p73
induction by cisplatin. c-jun(-/-) cells are defective in
p73
induction, and ectopic
c-Jun
expression augments
p73
levels.
c-Jun
-mediated accumulation of
p73
requires the transactivation activity of
c-Jun
and occurs in a c-Abl- and Mdm2-independent manner.
c-Jun
expression increases
p73
half-life by preventing it from proteasome-mediated degradation, resulting in the potentiation of
p73
-mediated transcriptional activity. Moreover, mouse fibroblasts lacking
c-Jun
are resistant to cisplatin-induced apoptosis, and reintroduction of
c-Jun
restores
p73
activation and sensitivity to cisplatin. Furthermore,
p73
-mediated apoptosis is abrogated in c-jun(-/-) cells. Together, these findings demonstrate a possible role for
c-Jun
in regulating
p73
function and highlight the importance of the cooperativity between transcription factors in potentiating apoptosis.
...
PMID:c-Jun regulates the stability and activity of the p53 homologue, p73. 1530 67
The p53 family member,
p73
, is essential for the survival of sympathetic neurons during the developmental period of naturally occurring neuronal death. Here, we have asked whether DeltaNp73, which is the only
p73
isoform expressed in sympathetic neurons, mediates this survival by p53-dependent and/or p53-independent mechanisms. Initially, we used a genetic approach and crossed p53+/- and p73+/- mice. Quantitation of neurons in the sympathetic superior cervical ganglion during the period of naturally occurring cell death revealed that the loss of p53 partially rescued the death of neurons seen in
p73
-/- animals. Moreover, exogenous expression of DeltaNp73 in cultured p53-/- sympathetic neurons rescued these neurons from apoptosis after NGF withdrawal. Biochemical studies asking how DeltaNp73 inhibited NGF withdrawal-induced apoptosis in wild-type neurons demonstrated that it prevented the upregulation of the direct p53 targets p21 and Apaf-1 as well as cleavage of caspase-3. It also inhibited events at the mitochondrial apoptotic checkpoint, suppressing the induction of BimEL and the release of mitochondrial cytochrome c. Interestingly, DeltaNp73 expression also inhibited one very early event in the apoptotic cascade, the activation of
c-Jun
N-terminal protein kinase (JNK), likely by binding directly to JNK. Finally, we show that neuronal cell size is decreased in
p73
-/- mice, and that this decrease is not rescued by the lack of p53, suggesting a role for
p73
in regulating cell size that does not involve interactions with p53. Thus, DeltaNp73 promotes neuronal survival via p53-dependent and -independent mechanisms, and it does so at multiple points, including some of the most proximal events that occur after NGF withdrawal.
...
PMID:Evidence that DeltaNp73 promotes neuronal survival by p53-dependent and p53-independent mechanisms. 1548 36
Here, we investigated the intracellular mechanisms that underlie the relative invulnerability of adult versus developing dorsal root ganglion (DRG) sensory neurons. In culture, adult neurons were resistant to stimuli that caused apoptosis of their neonatal counterparts. In both adult and neonatal neurons, death stimuli induced the apoptotic
c-Jun
N-terminal protein kinase (JNK) pathway, but JNK activation only caused death of neonatal neurons, indicating that adult neurons have a downstream block to apoptosis. Expression of the dominant-inhibitory p53 family member, DeltaNp73, rescued JNK-induced apoptosis of neonatal neurons, suggesting that it might participate in the downstream apoptotic block in adult neurons. To test this possibility, we examined adult DRG neurons cultured from p73+/- mice. Adult p73+/- DRG neurons were more vulnerable to apoptotic stimuli than their p73+/+ counterparts, and invulnerability could be restored to the p73+/- neurons by increased expression of DeltaNp73. Moreover, although DRG neuron development was normal in p73+/- animals in vivo, axotomy caused death of adult p73+/- but not p73+/+ DRG neurons. Thus, one way adult neurons become invulnerable is to enhance endogenous survival pathways, and one critical component of these survival pathways is
p73
.
...
PMID:The invulnerability of adult neurons: a critical role for p73. 1550 51
The activator protein-1 (AP1) transcription complex remains active for long periods after axotomy, but its activity diminishes during target contact. This raises the possibility that the function of this complex is regulated by the synaptic connections. Using Aplysia californica, we found that crushing peripheral nerves in vivo enhanced AP1 binding in the sensory neurons that lasted for weeks and then declined as regeneration was completed. The AP1 complex in Aplysia is a
c-Jun
homodimer. Its activation, after axotomy, is mediated by Aplysia
c-Jun
-N-terminal kinase (apJNK), which enters the nucleus of sensory neurons and phosphorylates
c-Jun
at Ser-73 (
p73
-
c-Jun
). Active AP1 in the sensory neurons did not mediate apoptosis and was not involved in the appearance of the long-term hyperexcitability that develops in these cells after axotomy, and blocking the activation of apJNK in vitro did not influence neurite outgrowth. In contrast, the levels of activated apJNK and
p73
-
c-Jun
declined markedly when sensory neurons formed synapses with motor neuron L7 in vitro. Furthermore, inhibiting the pathway accelerated synaptogenesis between sensory neurons and L7. These data suggest that positive and negative modulation of the JNK-
c-Jun
-AP1 pathway functions in alerting the nucleus to the loss and gain of synapses, respectively.
...
PMID:Synaptogenesis regulates axotomy-induced activation of c-Jun-activator protein-1 transcription. 1677 31
The cause or consequence of overexpression of
p73
(refs 1, 2), the structural and functional homologue of the tumour-suppressor gene product p53 (refs 3, 4), in human cancers is poorly understood. Here, we report a role for
p73
in supporting cellular growth through the upregulation of AP-1 transcriptional activity.
p73
suppresses growth when overexpressed alone, but synergises with the proto-oncogene
c-Jun
to promote cellular survival. Conversely, silencing of
p73
expression compromises cellular proliferation. Molecular analysis revealed that expression of the AP-1 target-gene product cyclinD1 (ref. 5) is reduced concomitant with
p73
, but not p53, silencing. Moreover, cyclinD1 was induced by
p73
expression in a
c-Jun
-dependent manner, and was required for
p73
-mediated cell survival. Furthermore,
c-Jun
-dependent AP-1 transcriptional activity was augmented by
p73
and, consistently, induction of endogenous AP-1 target genes was compromised in the absence of
p73
. Chromatin immunoprecipitation and electrophoretic mobility shift analysis indicated that
p73
enhanced the binding of phosphorylated
c-Jun
and Fra-1, another AP-1 family member, to AP-1 consensus DNA sequences, by regulating
c-Jun
phosphorylation and Fra-1 expression. Collectively, our data demonstrates a novel and unexpected role of
p73
in augmenting AP-1 transcriptional activity through which it supports cellular growth.
...
PMID:p73 supports cellular growth through c-Jun-dependent AP-1 transactivation. 1749 87
Nedd4-binding partner-1 (N4BP1) has been identified as a protein interactor and a substrate of the homologous to E6AP C terminus (HECT) domain-containing E3 ubiquitin-protein ligase (E3), Nedd4. Here, we describe a previously unrecognized functional interaction between N4BP1 and Itch, a Nedd4 structurally related E3, which contains four WW domains, conferring substrate-binding activity. We show that N4BP1 association with the second WW domain (WW2) of Itch interferes with E3 binding to its substrates. In particular, we found that N4BP1 and
p73
alpha, a target of Itch-mediated ubiquitin/proteasome proteolysis, share the same binding site. By competing with
p73
alpha for binding to the WW2 domain, N4BP1 reduces the ability of Itch to recruit and ubiquitylate
p73
alpha and inhibits Itch autoubiquitylation activity both in in vitro and in vivo ubiquitylation assays. Similarly, both
c-Jun
and p63 polyubiquitylation by Itch are inhibited by N4BP1. As a consequence, genetic and RNAi knockdown of N4BP1 diminish the steady-state protein levels and significantly impair the transcriptional activity of Itch substrates. Notably, stress-induced induction of
c-Jun
was impaired in N4BP1(-/-) cells. These results demonstrate that N4BP1 functions as a negative regulator of Itch. In addition, because inhibition of Itch by N4BP1 results in the stabilization of crucial cell death regulators such as
p73
alpha and
c-Jun
, it is conceivable that N4BP1 may have a role in regulating tumor progression and the response of cancer cells to chemotherapy.
...
PMID:The Nedd4-binding partner 1 (N4BP1) protein is an inhibitor of the E3 ligase Itch. 1759 38
The peptidyl prolyl cis/trans isomerase Pin1 specifically binds phosphorylated Ser/Thr-Pro protein motifs and catalyzes the cis/trans isomerization of the peptide bond. Accumulating studies have revealed that Pin1 isomerase activity is regulated by its post-translational modifications, including phosphorylation and oxidation. Various transcription factors and regulators have been identified as substrates for Pin1. It enhances AP-1 activity via isomerization of both
c-Jun
and c-Fos for cellular proliferation and stabilizes the oncosuppressors p53 and
p73
against DNA damage at the checkpoint. We demonstrated the association between the intracellular form of Notch1 (NIC) and Pin1 by analyzing Pin1/p53 double-knockout mice. Pin1 also regulates the post-transcriptional level of some cytokines, associated with asthma, that possess 3' untranslated region AU-rich elements (AREs) via interaction withAUF1, the nucleoprotein in the ARE-binding complex. Pin1 has been identified as the molecular partner of tau and amyloid precursor protein (APP), the key factors of Alzheimer's disease (AD). It interacts with the phosphorylated Thr-231 of tau and regulates its activity to bind microtubules. It further interacts with the phosphorylated Thr-668 of APP and affects its metabolism. Thus, Pin1 is probably involved in the pathogenesis of human diseases, including cancer, asthma, and AD, presenting an attractive target for future therapeutical drugs.
...
PMID:Prolyl isomerase, Pin1: new findings of post-translational modifications and physiological substrates in cancer, asthma and Alzheimer's disease. 1796 33
Loss of heterozygosity and chromosomal rearrangement of the WWOX gene, which is located at 16q23.3-24.1, have been detected in ovarian, breast, hepatocellular, and prostate carcinomas and in other neoplasias. This gene, which spans the common chromosomal fragile site 16D, contains 9 exons and encodes a 46 kDa WWOX protein that contains 414 amino acids. The evidence from cancer cell lines and primary tumor tissues suggests that WWOX is a tumor suppressor gene and that its inactivation contributes to cancer development. The results from studies of WWOX gene knockout cancer cells and a WWOX knockout mouse model partly confirm this hypothesis. The nature of the various proteins that the WWOX protein can interact with, such as
c-Jun
, TNF, p53,
p73
, AP-2 gamma, and E2F-1, suggests that WWOX plays a central role in tumor suppression through transcriptional repression and apoptosis, with its apoptotic function the more prominent of the two. However, there is not universal agreement that WWOX is a tumor suppressor gene. Further analysis is needed to reveal the true nature of WWOX.
...
PMID:WWOX tumor suppressor gene. 1843 86
We have compiled the
p73
-mediated cell cycle arrest and apoptosis pathways.
p73
is a member of the p53 family, consisting of p53, p63 and
p73
.
p73
exists in several isoforms, presenting different domain structures.
p73
functions not only as a tumor suppressor in apoptosis but also as differentiator in embryo development. p53 mutations are responsible for half of the human cancers;
p73
can partially substitute mutant p53 as tumor suppressor. The pathways we assembled create a
p73
-centered network consisting of 53 proteins and 176 interactions. We clustered our network into five functional categories: Upregulation, Activation, Suppression, Transcriptional Activity and Degradation. Our literature searches led to discovering proteins (
c-Jun
and pRb) with apparent opposing functional effects; these indicate either currently missing proteins and interactions or experimental misidentification or functional annotation. For convenience, here we present the
p73
network using the molecular interaction map (MIM) notation. The
p73
MIM is unique amongst MIMs, since it further implements detailed domain features. We highlight shared pathways between p53 and
p73
. We expect that the compiled and organized network would be useful to p53 family-based studies.
...
PMID:Cataloging and organizing p73 interactions in cell cycle arrest and apoptosis. 1866 May 13
1
2
Next >>